BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16907856)

  • 1. Expression profiling of apoptosis-related genes in enterocytes isolated from patients with ulcerative colitis.
    Seidelin JB; Nielsen OH
    APMIS; 2006; 114(7-8):508-17. PubMed ID: 16907856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations.
    Planell N; Lozano JJ; Mora-Buch R; Masamunt MC; Jimeno M; Ordás I; Esteller M; Ricart E; Piqué JM; Panés J; Salas A
    Gut; 2013 Jul; 62(7):967-76. PubMed ID: 23135761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha.
    Wu F; Zikusoka M; Trindade A; Dassopoulos T; Harris ML; Bayless TM; Brant SR; Chakravarti S; Kwon JH
    Gastroenterology; 2008 Nov; 135(5):1624-1635.e24. PubMed ID: 18835392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth in epithelial cell proliferation and apoptosis correlates specifically to the inflammation activity of inflammatory bowel diseases: ulcerative colitis shows specific p53- and EGFR expression alterations.
    Sipos F; Molnár B; Zágoni T; Berczi L; Tulassay Z
    Dis Colon Rectum; 2005 Apr; 48(4):775-86. PubMed ID: 15747078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in the proliferation and apoptosis of colonic epithelial cells in correlation with histologic activity of ulcerative colitis].
    Sipos F; Zágoni T; Molnár B; Tulassay Z
    Orv Hetil; 2002 Nov; 143(44):2485-8. PubMed ID: 12674803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of the TRAIL/TRAIL-receptor system in patients with inflammatory bowel disease.
    Brost S; Koschny R; Sykora J; Stremmel W; Lasitschka F; Walczak H; Ganten TM
    Pathol Res Pract; 2010 Jan; 206(1):43-50. PubMed ID: 19954896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
    Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
    Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers.
    Endo Y; Marusawa H; Kou T; Nakase H; Fujii S; Fujimori T; Kinoshita K; Honjo T; Chiba T
    Gastroenterology; 2008 Sep; 135(3):889-98, 898.e1-3. PubMed ID: 18691581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression in histologically normal crypts of ulcerative colitis suggests primary crypt disorder.
    Kim M; Lee S; Yang SK; Song K; Lee I
    Oncol Rep; 2006 Oct; 16(4):663-70. PubMed ID: 16969477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory gene signature in ulcerative colitis with cDNA macroarray analysis.
    Okahara S; Arimura Y; Yabana T; Kobayashi K; Gotoh A; Motoya S; Imamura A; Endo T; Imai K
    Aliment Pharmacol Ther; 2005 May; 21(9):1091-7. PubMed ID: 15854170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profiling of ulcerative colitis-associated neoplastic progression.
    Colliver DW; Crawford NP; Eichenberger MR; Zacharius W; Petras RE; Stromberg AJ; Galandiuk S
    Exp Mol Pathol; 2006 Feb; 80(1):1-10. PubMed ID: 16277983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expressing the differences between Crohn disease and ulcerative colitis.
    Wijmenga C
    PLoS Med; 2005 Aug; 2(8):e230; quiz e304. PubMed ID: 16120009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways.
    Rizzatti EG; Falcão RP; Panepucci RA; Proto-Siqueira R; Anselmo-Lima WT; Okamoto OK; Zago MA
    Br J Haematol; 2005 Aug; 130(4):516-26. PubMed ID: 16098065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bcl-2/Bax system and apoptosis in ulcerative colitis.
    Karamanolis DG; Kyrlagkitsis I; Konstantinou K; Papatheodoridis GV; Karameris A; Mallas E; Ladas SD; Raptis S
    Hepatogastroenterology; 2007 Jun; 54(76):1085-8. PubMed ID: 17629044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visilizumab induces apoptosis of mucosal T lymphocytes in ulcerative colitis through activation of caspase 3 and 8 dependent pathways.
    Yu QT; Saruta M; Papadakis KA
    Clin Immunol; 2008 Jun; 127(3):322-9. PubMed ID: 18424236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
    Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
    Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin-like growth factor receptor, hepatocyte-derived growth factor receptor and telomerase expression in ulcerative colitis].
    Sipos F; Molnár B; Zágoni T; Miheller P; Tulassay Z
    Orv Hetil; 2006 Sep; 147(38):1835-41. PubMed ID: 17066600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis.
    Arijs I; Li K; Toedter G; Quintens R; Van Lommel L; Van Steen K; Leemans P; De Hertogh G; Lemaire K; Ferrante M; Schnitzler F; Thorrez L; Ma K; Song XY; Marano C; Van Assche G; Vermeire S; Geboes K; Schuit F; Baribaud F; Rutgeerts P
    Gut; 2009 Dec; 58(12):1612-9. PubMed ID: 19700435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial apoptosis: cause or consequence of ulcerative colitis?
    Seidelin JB; Nielsen OH
    Scand J Gastroenterol; 2009; 44(12):1429-34. PubMed ID: 19958058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
    Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.